Compliance

Testing the New AAHP Disclaimer for Effectiveness

January 30, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

New Drug Listing Requirement and Timetable Effective this Month

October 3, 2017

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

How is Homeopathic Belladonna Made?

September 5, 2017

By Mark Land, AAHP president September 1, 2017 Belladonna, more commonly known as deadly nightshade, Atropa belladonna, devil’s cherries, devil’s herb, divale, dwale, dwayberry, great morel, naughty man’s cherries, and poison black cherry, is a perennial herb that has been valued for its medicinal properties for more than five centuries. Belladonna is a member of the…

The Road to OTC Monograph Reform

August 3, 2017

By Barbara A. Kochanowski, senior vice president of regulatory and scientific affairs Consumer Healthcare Products Association August 1, 2017 For the past three years, the regulated industry has been working with the U.S. Food and Drug Administration (FDA) to reform the OTC Monograph System, the regulatory framework under which most over-the-counter (OTC) products are regulated.…

Changes are Coming to Product Labels

July 26, 2017

By Alvin J. Lorman, AAHP counsel August 1, 2017 Changes are coming to your products’ labels. Not only are there changes to the Homeopathic Pharmacopeia of the United States (HPUS) on the horizon, but our association’s Board of Directors is expected to make its soon-to-be-adopted new advertising disclaimer mandatory on labels as well. And there’s…

OTC Monograph Reform

July 25, 2017

By Mark Land, AAHP president August 1, 2017 Self-medication is an important way in which American consumers treat many types of illnesses. Over-the-counter (OTC) drugs often provide effective relief in a cost-effective and accessible manner and represent the first choice of treatment for many ailments. More than 80 therapeutic categories of OTC drugs exist and…

The Homeopathic Pharmacopoeia of the United States

May 31, 2017

By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and many other countries around the world. The HPUS is officially recognized in the United States Federal Food Drug and Cosmetic Act and other United States…

2017 Updates in the Homeopathic Pharmacopeia

May 31, 2017

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest: The Guidelines for Manufacturing Homeopathic Medicines became official on March 31, 2017. The older General Pharmacy section and the Classes of Manufacture are no longer…

What is the HPUS and Who Creates It?

May 31, 2017

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Various pharmacopoeias containing homeopathic drugs have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication for 120 years — since 1897. The HPUS was officially recognized under the U.S. Food Drug and Cosmetic Act…

Disclaimers in Advertising and Labeling: What Do They Do? Who Does What?

April 26, 2017

By Mark Land, AAHP President The FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading. This is FTC’s way of saying disclaimers may cure potentially misleading claims in general or, in our case, homeopathic therapeutic claims specifically. Communicating information to consumers in the noisy marketplace…

Leave a Comment

You must be logged in to post a comment.